Editions:  Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland
Advertisement

Italy seeks €1.2bn over 'illicit' Swiss drug deal

Share this article

Italy seeks €1.2bn over 'illicit' Swiss drug deal
Italy is seeking €1.2 billion in compensation from Novartis and Roche. Photo: Sebastien Bozon/AFP
08:24 CEST+02:00
Italy's health ministry is seeking €1.2 billion in compensation from Swiss pharma giants Novartis and Roche for the manipulation of sales of a cheap drug used to treat eye problems, Italian media reported on Wednesday.

The ministry's move came after Italy's antitrust body fined the two firms €182.5 million over their "illicit deal to prevent the use of a very cheap drug, Avastin, in treating" sight problems.

The antitrust body said the two pharma giants had colluded with the aim of boosting the sales of a more expensive product, Lucentis. It also claimed that they steered health services and doctors away from Avastin by describing it as more dangerous.

Both Roche and Novartis market Lucentis as the best medicine for the eye disease known as macular degeneration.

Novartis has rejected the anti-competition accusations and has said it would appeal against the fine.

Don't miss a story about Italy - Join us on Facebook and Twitter.

Get notified about breaking news on The Local

Share this article

Advertisement

From our sponsors

The Swedish university where students tackle real-world problems

Ranked among the world's best young universities in the QS Top 50 Under 50, Linköping University (LiU) uses innovative learning techniques that prepare its students to tackle the challenges of tomorrow.

Advertisement
Advertisement
Jobs
Click here to start your job search
Advertisement
Advertisement

Popular articles

Advertisement
Advertisement